Common Treatment for Pregnant Women May Be Ineffective
A common treatment for pregnant women prone to blood clots is a daily injection of blood thinner into the stomach. It's intended to prevent pregnancy complications, but recent research suggests this treatment may not work.
Reports Claim Drug Company Withheld Important Safety Information
The maker of a new anti-clotting medication may have withheld important safety information from regulators, according to several new reports.
FDA Approves New Cancer Medication
The US Food and Drug Administration (FDA) approved Zydelig (idelalisib) today to treat patients with three types of blood cancers.
HPV Shot Not Linked to Blood Clots
One of the few vaccines that can actually protect against cancer is the human papillomavirus (HPV) vaccine, which prevents four strains of HPV. But some parents have expressed concerns about the safety of the HPV vaccine.
Clot-Busting Therapy for Pulmonary Embolism Lowered Death Risk
Pulmonary embolism is a condition that can strike suddenly, sometimes with deadly consequences. New research on treatments for the condition could lead to better outcomes and understanding of risk factors.
Many Minority Kids With Cancer Missed Needed Medication
Children in remission from leukemia, the most common childhood cancer, need to take a certain medication to keep the cancer from coming back. But some of these children are not receiving all the medication they need.
Mega-Dose of Measles Vaccine Killed Cancer
Multiple myeloma is a cancer that develops in the bone marrow and is considered by many to be incurable. An engineered measles virus, however, may change that.
Why Childhood Cancer Survival Rates Have Increased
With increasing survival rates for many types of childhood cancers, some of these cancers are approaching cures. Several key events have made this possible.
Traffic May be Deadly, But Not the Way You’d Expect
Many people consider living near traffic to be dangerous for children, fearing accidents. New research suggests that traffic can be harmful to children for other reasons.
New Mothers May Need Longer Monitoring for Blood Clots
It is normal for new mothers to be at risk for a blood clot for six weeks after giving birth. However, a new study suggests that women may still be at risk after those first six weeks.